|
Targacept reports error in asthma study
Triad Business Journal Targacept disclosed an error in the analysis of a potential asthma treatment, but says the candidate still holds promise. Targacept said an error in the analysis of a drug it recently studied as a potential treatment for asthma affected the results, … Targacept Announces Revised Top-Line Results from Exploratory Phase 2 Study of … Targacept Revises Results Of Exploratory Drug Study; Shares Slump Targacept Reports Revised Top-Line Results From Phase 2 Study Of TC-6987 |
View full post on asthma – Google News